Literature DB >> 28038349

Imine reductases (IREDs).

Juan Mangas-Sanchez1, Scott P France1, Sarah L Montgomery1, Godwin A Aleku1, Henry Man2, Mahima Sharma2, Jeremy I Ramsden1, Gideon Grogan2, Nicholas J Turner3.   

Abstract

Imine reductases (IREDs) have emerged as a valuable new set of biocatalysts for the asymmetric synthesis of optically active amines. The development of bioinformatics tools and searchable databases has led to the identification of a diverse range of new IRED biocatalysts that have been characterised and employed in different synthetic processes. This review describes the latest developments in the structural and mechanistic aspects of IREDs, together with synthetic applications of these enzymes, and identifies ongoing and future challenges in the field.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28038349     DOI: 10.1016/j.cbpa.2016.11.022

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  26 in total

1.  Screening and characterization of a diverse panel of metagenomic imine reductases for biocatalytic reductive amination.

Authors:  James R Marshall; Peiyuan Yao; Sarah L Montgomery; James D Finnigan; Thomas W Thorpe; Ryan B Palmer; Juan Mangas-Sanchez; Richard A M Duncan; Rachel S Heath; Kirsty M Graham; Darren J Cook; Simon J Charnock; Nicholas J Turner
Journal:  Nat Chem       Date:  2020-12-30       Impact factor: 24.427

2.  A reductive aminase from Aspergillus oryzae.

Authors:  Godwin A Aleku; Scott P France; Henry Man; Juan Mangas-Sanchez; Sarah L Montgomery; Mahima Sharma; Friedemann Leipold; Shahed Hussain; Gideon Grogan; Nicholas J Turner
Journal:  Nat Chem       Date:  2017-05-29       Impact factor: 24.427

Review 3.  The role of biocatalysis in the asymmetric synthesis of alkaloids - an update.

Authors:  Emmanuel Cigan; Bettina Eggbauer; Joerg H Schrittwieser; Wolfgang Kroutil
Journal:  RSC Adv       Date:  2021-08-20       Impact factor: 3.361

Review 4.  Multistep enzyme cascades as a route towards green and sustainable pharmaceutical syntheses.

Authors:  Ana I Benítez-Mateos; David Roura Padrosa; Francesca Paradisi
Journal:  Nat Chem       Date:  2022-05-05       Impact factor: 24.274

Review 5.  Recent advances in imine reductase-catalyzed reactions.

Authors:  Maike Lenz; Niels Borlinghaus; Leonie Weinmann; Bettina M Nestl
Journal:  World J Microbiol Biotechnol       Date:  2017-10-11       Impact factor: 3.312

6.  Characterization of imine reductases in reductive amination for the exploration of structure-activity relationships.

Authors:  Sarah L Montgomery; Ahir Pushpanath; Rachel S Heath; James R Marshall; Ulrike Klemstein; James L Galman; David Woodlock; Serena Bisagni; Christopher J Taylor; J Mangas-Sanchez; J I Ramsden; Beatriz Dominguez; Nicholas J Turner
Journal:  Sci Adv       Date:  2020-05-22       Impact factor: 14.136

7.  Sequence-Based In-silico Discovery, Characterisation, and Biocatalytic Application of a Set of Imine Reductases.

Authors:  Stefan Velikogne; Verena Resch; Carina Dertnig; Joerg H Schrittwieser; Wolfgang Kroutil
Journal:  ChemCatChem       Date:  2018-07-17       Impact factor: 5.686

Review 8.  Recent trends in biocatalysis.

Authors:  Dong Yi; Thomas Bayer; Christoffel P S Badenhorst; Shuke Wu; Mark Doerr; Matthias Höhne; Uwe T Bornscheuer
Journal:  Chem Soc Rev       Date:  2021-06-18       Impact factor: 60.615

9.  Asymmetric Alkylation of Ketones Catalyzed by Engineered TrpB.

Authors:  Ella J Watkins-Dulaney; Noah P Dunham; Sabine Straathof; Soma Turi; Frances H Arnold; Andrew R Buller
Journal:  Angew Chem Int Ed Engl       Date:  2021-08-18       Impact factor: 16.823

Review 10.  NAD(P)H-Dependent Dehydrogenases for the Asymmetric Reductive Amination of Ketones: Structure, Mechanism, Evolution and Application.

Authors:  Mahima Sharma; Juan Mangas-Sanchez; Nicholas J Turner; Gideon Grogan
Journal:  Adv Synth Catal       Date:  2017-05-11       Impact factor: 5.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.